Evidence map›Paper›PMID 41206765›Full record

Observational studyNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2026

Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox.

Changyuan Yang, Biyi Liao, Priya Vart, David W Johnson, Ron T Gansevoort, Guobin Su

Abstract readObservational Study
In one paragraph

Observational study in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Changyuan YangDepartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-7153-9159
Biyi LiaoState Key Laboratory of Traditional Chinese Medicine Syndrome, Chinese Medicine Guangdong Laboratory, Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Big Data Research Center of Chinese Medicine, Department of Nephrology, Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Priya VartDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-5576-820X
David W JohnsonAustralasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
Ron T GansevoortDepartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Guobin SuState Key Laboratory of Traditional Chinese Medicine Syndrome, Chinese Medicine Guangdong Laboratory, Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Big Data Research Center of Chinese Medicine, Department of Nephrology, Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID 0000-0001-5073-9848

Funding

Karolinska Institutet 2020-01616Karolinska Institutet 2022-02044National Natural Science Foundation of China 82004205National Natural Science Foundation of China 82174308National Science and Technology Major Project 2023ZD0505600National Science and Technology Major Project 2023ZD0505604Noncommunicable Chronic DiseasesProvincial Hospital of Chinese Medicine YN2020QN18Provincial Hospital of Chinese Medicine YN2020QN24Provincial Hospital of Chinese Medicine YN2024MB018Provincial Hospital of Chinese Medicine YN2024MS012Sanming Project of Medicine in Shenzhen SZZYSM202206014
6 · The paper itself

Abstract

backgroundBody roundness index (BRI), an emerging anthropometric measure, has been shown to outperform body mass index (BMI) in predicting mortality risk in the general population. However, its prognostic value among patients with chronic kidney disease (CKD), where the obesity paradox may exist, remains unknown.

methodsThis observational study utilized data from the National Health and Nutrition Examination Survey. BRI was calculated using waist circumference (WC) and height, whereas BMI was calculated using body weight and height. Restricted cubic splines (RCSs) were applied to determine optimal cut-off points of BRI for all-cause and cardiovascular mortality in patients with CKD. Associations were examined using Cox proportional hazards models adjusted for potential confounders.

resultsOver a median follow-up of 6.6 years, 6240 patients with CKD (mean age 63 years, 43% men) were included, with 1922 all-cause and 715 cardiovascular deaths recorded. RCSs demonstrated J-shaped associations between BRI with mortality. A BRI >10 was associated with a significantly increased risk of all-cause {adjusted hazard ratio [aHR] 1.82 [95% confidence interval (CI) 1.34-2.47]} and cardiovascular mortality [aHR 2.15 (95% CI 1.27-3.62)] compared with the reference of 5.9-6.8 and 5.9-6.5, respectively, with dose-response trends (P for trend < .05). A BMI >30 was paradoxically associated with 44% and 40% lower risks of all-cause and cardiovascular mortality compared with the reference of 18.5-25, respectively. A WC >125  was associated with an increased risk of all-cause mortality [aHR 2.17 (95% CI 1.47-3.18)] but not with cardiovascular mortality [aHR 1.83 (95% CI 0.97-3.45)] compared with the reference of 95-105 cm. The associations between BRI >10 and mortality risks were particularly pronounced among younger adults <65 years of age or individuals with elevated albuminuria (P for interaction < .05).

conclusionsHigher BRI was independently associated with increased all-cause and cardiovascular mortality risk among patients with CKD, offering greater prognostic value for risk stratification than BMI or WC.

Indexed as

Body Mass IndexCardiovascular DiseasesObesityRenal Insufficiency, ChronicWaist CircumferenceAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedNutrition SurveysObesity ParadoxPrognosisRisk FactorsSurvival Ratebody mass indexbody roundness indexcardiovascular eventobesitywaist circumference

Identifiers

PMID41206765
PMCPMC13218931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.